Amanote Research
Register
Sign In
Cyclin D1 (CCND1; BCL1); Epiregulin (EREG); Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B; P27; Kip1); Epidermal Growth Factor Receptor (EGFR); HER2 (ERBB2; Neu)
Science-Business eXchange
doi 10.1038/scibx.2009.175
Full Text
Open PDF
Abstract
Available in
full text
Date
February 1, 2009
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers
Clinical Cancer Research
Cancer Research
Oncology
Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B) Gene Variants in AIP Mutation-Negative Familial Isolated Pituitary Adenoma Kindreds
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
The Serine/Threonine Kinase Cyclin G-Associated Kinase Regulates Epidermal Growth Factor Receptor Signaling
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
HER2 (ERBB2; Neu); Transferrin Receptor
Science-Business eXchange
Transcriptional Profiling Identifies Cyclin D1 as a Critical Downstream Effector of Mutant Epidermal Growth Factor Receptor Signaling
Cancer Research
Cancer Research
Oncology
Inactivation of the Cyclin-Dependent Kinase Inhibitor P27 Upon Loss of the Tuberous Sclerosis Complex Gene-2
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
HER2 (EGFR2; ErbB2; Neu)
Science-Business eXchange
Epidermal Growth Factor-Stimulated Human Cervical Cancer Cell Growth Is Associated With EGFR and Cyclin D1 Activation, Independent of COX-2 Expression Levels
International Journal of Oncology
Cancer Research
Oncology
Cyclin-Dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis
Journal of Clinical Investigation
Medicine
